Accurate estimates for healthcare associated infections – Full Text
“Conversely, no significant difference was found between incidence rates estimated based on weighted VAP and CLABSI prevalence and measured through GiViTI (p = 0.927 and 0.503 respectively)” Vicentini et al (2024).
Factors associated with CRBSI mortality – Full Text
“Enhanced monitoring of factors, such as candida detected in blood culture, CRBSI onset within 30 days of catheter insertion, concurrent infection, low serum albumin level, elevated C-reactive protein (CRP) level and the use of a peripherally inserted central catheter (PICC), is crucial for mitigating CRBSI severity and risk of death” Futamura et al (2024).
Reducing central line-associated bloodstream infections
“This study aimed to assess the effectiveness of multi-department cooperation, intelligent prevention, and supervision (MDCIPS) in reducing the incidence of CLABSIs and improving the clinical outcomes of the patients” Wu et al (2024).
Identifying central line-associated bloodstream infections – Full Text
“We evaluated one of the first secure large language models approved for protected health information, for identifying central line-associated bloodstream infections (CLABSIs) using real clinical notes” Rodriguez-Nava et al (2024).
Demographic-based disparities in CLABSI outcomes – Full Text
“This study highlights significant disparities in CLABSI outcomes based on demographic factors. Addressing these disparities is crucial for improving CLABSI management and healthcare equity. Further research should explore the underlying causes of these differences to inform targeted interventions” Dix et al (2024).
Blood culture results trigger of timely CLABSI identification – Full Text
“To address incorrect classifications of infectious events as CLABSI, the surveillance process was changed from using finalized blood culture to preliminary blood culture results as trigger of timely, in-depth reviews” Bischoff et al (2024).
CLABSI risk associated with ethnicity and socioeconomic disparities – Full Text
“We did not find a difference in CLABSI risk between non-Hispanic White and non-Hispanic Black patients when adjusting for CLABSI risk inherent in type and configuration of CVC” Gottlieb et al (2024).
Targeted single-dose antibiotics to reduce CLABSI – Full Text
“Alteplase use has been associated with CLABSIs. Providing a single dose of post-alteplase antibiotics targeting the most likely site-specific pathogens may reduce the incidence of CLABSIs” Watchorn et al (2024).
CLABSI reduction in preterm neonates
“To compare the incidence of central line associated blood stream infections (CLABSI) with the use of umbilical venous catheters (UVC) as primary vascular access in preterm neonates with peripherally inserted central catheters (PICC)” Arun et al (2024).
Central catheter-associated bloodstream infection surveillance
“Prospective CLABSI surveillance indicated stable incidence densities per 1000 catheter-days, but there were significant shifts of causative microorganisms over time” Obenhuber et al (2024).
Risk factors for CLABSI in pediatric intensive care – Full Text
“Pediatric intensive care patients with chronic CVCs receiving parenteral nutrition, those on non-opioid sedative infusions, and those with more central line days are at increased risk for CLABSI despite current prevention measures” Marks et al (2024).
CLABSI outbreak following contaminated saline incident – Full Text
“The characteristics of R. pickettii-related central line-associated bloodstream infection (CLABSI) outbreak in pediatric hematopoietic stem cell transplant (HSCT) recipients are presented in this study” Çelen et al (2024).
CLABSI rates in Colombia 2015-2018 – Full Text
“Central line-associated bloodstream infections (CLABSIs) are a significant healthcare challenge globally, increasing mortality risk and complicating central vascular catheter use. In Colombia, few studies have assessed the impact of CLABSIs on hospital stay and mortality” Mosquera et al (2024).
Reducing catheter-related bloodstream infections – Full Text
“This study aims to evaluate the effectiveness of Lean Six Sigma in mitigating CRBSI risks among non-ICU hemodialysis patients” Feng et al (2024).
Central line-associated bloodstream infection rates in children – Full Text
“Failure to adjust for patient factors, particularly acuity and complexity of disease, may miss clinically significant differences in CLABSI rates, and may lead to inaccurate interpretation of the impact of quality improvement efforts” Srinivasan et al (2024).
CRBSI in hemodialysis patients – Full Text
“The incidence of CRBSI was found to be 0.78 episodes per 1,000 catheter-days. Acute hemodialysis catheter type and anemia were associated with increased risk for CRBSI, with a P-value less than 0.05” Bitunguramye et al (2024).
CLABSI differences according to catheter type – Full Text
“CABSI in catheters other than short-term non-tunnelled CVC are more commonly caused by virulent organisms including S. aureus and Gram-negative bacteria. Catheter type should be considered when selecting empirical antimicrobial therapies” MacPhail et al (2024).
Clinical decision support system to reduce CLABSI – Full Text
” A significant proportion of active CVLs were potentially unnecessary. CDSS implementation, in conjunction with audit and feedback, correlated with a sustained increase in timely CVL removal and an increase in days between CLABSIs” Spiegel et al (2024).
Device associated healthcare associated infection – Full Text
“This study investigates the impact of invasive procedures on healthcare-associated infections (HAI) at Policlinico Universitario Tor Vergata in Rome, Italy, aiming to understand their role in device-associated HAI and to inform prevention strategies” Guarente et al (2024).
Racial disparities in central line-associated bloodstream infections – Full Text
“This retrospective cohort study analyzed differences in rates of central line-associated bloodstream infections (CLABSI) in Black and White inpatients across 11 southeastern US hospitals from 2019 to 2021” DeWitt et al (2024).
Vascular access device post-removal sepsis
“To compare post-ECC or neonatal peripherally inserted central catheter (n-PICCs) removal sepsis rates when using conventional or antimicrobial-impregnated catheters in neonates” Al Khateeb et al (2024).
Effect of transdermal antimicrobial photodynamic therapy on catheter biofilms
“This experimental study aimed to examine the effectiveness of transdermal antimicrobial photodynamic therapy (APDT) with and without antimicrobial lock therapy (ALT), on catheter biofilms” Aysert-Yıldız et al (2024).
The CLABSI burden among outpatients – Full Text
“However, central lines (CLs) are increasingly used outside of acute care hospitals, in locations such as the patient home, outpatient infusion or chemotherapy centers, skilled nursing or long-term care facilities, home-based or facility-based dialysis centers, and rehabilitation facilities. CLABSIs that arise in these settings are not included in surveillance or reported systematically” Oladapo-Shittu et al (2024).
Hospital-acquired bloodstream infections in adult intensive care units – Full Text
“The major sources of bloodstream infection among adult ICU patients were VRE and Candida species. Mortality was common in this population, particularly among patients who were resistant to medication. Hence, strategies to reduce hospital-acquired bloodstream infections are warranted” Albudayri et al (2024).
Infection prevention strategies for nursing practice
“IPC measures are crucial in preventing infections such as catheter-associated urinary tract infections, central line-associated bloodstream infections, surgical site infections, and ventilator-associated pneumonia” Hill et al (2024).
Mucosal barrier injury central line-associated bloodstream infections
“These infections commonly occur by oral or gastrointestinal (GI) bacteria translocating through impaired gut or oral mucosa. Although strategies to prevent gut MBI-CLABSIs are well characterized, oral pathogen prevention strategies are lacking” Bledsaw et al (2024).
CLABSI rates based on insertion site location
“We aim to evaluate the association between central venous catheter (CVC) insertion site and microbiological CVC complications in a nationwide cohort” Cosme et al (2024).
COVID-19 infection and risk of candidaemia
“Patients in ICUs with COVID-19 infections have a much higher risk of candidaemia, CLAC and its associated mortality. Network level data helps in understanding the true burden of candidaemia and will help in framing infection control policies for the country” Mathur et al (2024).
Impact of the recent pandemic on CLABSI rates
“This article presents a summary of the impact of the recent SARS-CoV-2 pandemic on CLABSI incidence, an overview of current standard-of-care practices for reduction of CLABSI, and a look toward future changes in bacteremia metrics and challenges in prevention” Torres et al (2024).
CLABSI bundle associated with CLABSI reduction
“The CLABSI bundle was associated with a significant immediate effect in reducing the CLABSI rate in the SICU compared with control ICUs” Harris et al (2024).